Live
- Awareness Program in agricultural College on the Dangers of Drug Abuse for Youth
- 3500-Year-Old Menhir in Kamsanpally Village: A Call for Preservation
- The Role of Artificial Intelligence in Radiology: Transforming Diagnosis and Patient Care
- Hindustan Zinc Ltd. Signs MoU with Rajasthan Government to Invest Rs 36 Crores in Education Development
- Sales and Marketing: Synchronising Steps for Success
- MATTER begins deliveries of AERA from Ahmedabad, inaugurates first of its kind Experience Hub
- Transforming Education Infrastructure is the key to National Development: Neeraj Sharma, Auxilo Finserve
- Crimson Becomes the First Indian School to Receive WELL Health-Safety Certification for Measures to Boost Physical and Mental Wellbeing
- Trackon Celebrates 20 Years of Innovation and Growth in Logistics
- Hero Motocorp showcases its future mobility vision at Eicma 2024
Kurapati Krishnaiah is new CEO of Basavatarakam Indo-American Cancer Hospital & Research Institute
The Basavatarakam Indo-American Cancer Hospital and Research Institute here on Tuesday announced the appointment of Dr Kurapati Krishnaiah as its new Chief Executive Officer
Hyderabad : The Basavatarakam Indo-American Cancer Hospital and Research Institute here on Tuesday announced the appointment of Dr Kurapati Krishnaiah as its new Chief Executive Officer.
A distinguished orthopaedic surgeon with over 40 years of experience, Dr Krishnaiah brings a wealth of expertise to his new role, a release said. Welcoming Dr Krishnaiah, the Chairman Nandamuri Balakrishna and trustees of Basavatarakam Hospital spoke of his leadership, citing his exceptional track record in elevating healthcare standards and fostering research collaborations.
In addition to his clinical expertise, Dr Krishnaiah has made significant contributions to medical research, the release said. Dr Krishnaiah said : "It is an honour to lead an institution renowned for its commitment to cancer care. I am excited to collaborate with the team here to further enhance patient care, advance research, and continue the legacy of excellence."
